About Medio Labs
We're building the future of clinical diagnostic services.
Medio Labs is applying the very latest DNA engineering and sequencing technologies to revolutionize clinical diagnostic testing. The company's innovations are designed to radically expand access to the latest diagnostic technology with the goal of driving a wholesale shift from treating health crises after they occur, to regular advanced screening that prevents healthcare crises from occurring in the first place.
2018
Year we were founded
60,000+
Clinical tests processed in 2022
21+
Team members
20+
Number of diseases detected
Our approach
Impact Oriented
We are a diverse team of creative innovators who revel in making science fiction into real working technology with global impact.
At Medio Labs, we are driving a revolution in healthcare designed to massively reduce the cost of state-of-the-art clinical diagnostic testing and expand global access to quality care.
The company is applying deep expertise in clinical diagnostic assay design that leverages the latest next-generation sequencing platforms along with molecular bar codes written in RNA and attached chemically to patient samples to increase the scale and reduce the cost of quantifying multiple pathogens in every individual patient sample.
The impact of being able to test for multiple diseases that might have any number of symptoms in common using Just One Test is profound. Testing costs are dramatically reduced, Turn-around times are accelerated even in pandemic surges. Time to validated course of treatment is reduced, and patient outcomes improved.

Our values
Authenticity
We work on real problems that demand clear self knowledge, a recognition of important global challenges, and the difficulty of creating meaningful solutions that will have impact at large scale. We hold ourselves and our peers accountable.
Diversity
Complex global challenges demand complicated, multi-component and multi-approach solutions. So we emphasize diversity of thought, background, ethnicity, skills, and approach that make a whole team much more capable of generating transformative services than the cookie-cutter approaches accessible to more homogenous teams.
Excellence
When solving global challenges, there is no time to rest easy and just do more of what caused many of our problems. We have high standards of performance and self-motivation to excel, and accomplish what other consider impossible.
Transparency
We don't keep or horde knowledge for individual political power in the organization. We hold the company's collective mission as more important than individual advancement. We don't keep secrets or politics. We leave ego at the door, and work to make the best ideas happen wherever they arise. We share knowledge and training to help everyone excel, grow, and succeed.
Inspiration
There is never a dull moment or boring routine when working on global challenges. We work on problems that are so important and impactful that the reasons to get out of bed every morning are completely clear. We are working hard to improve healthcare for everyone in the world, and to offer even the poorest and most remote people access to care when before, they had none.
Service
We started Brainworks, and developed the Medio service specifically in service of global challenges that have defied easy solutions for decades. Our goal, put simply, is to use powerful new technology to save and extend lives.
Medio Labs Leadership
Our team of renowned experts offer their professional services to help your organization understand, plan for, and manage all aspects of the pandemic from general analytics of the pandemic and your organization’s pandemic response to facility risk assessment and upgrades, to pandemic operations. Medio Labs experts will work to design the best system for your needs and regularly examine your data to help you identify hot spots and minimize COVID-19 infection rates, outbreaks, and shut-downs.

Michael Boyd
Chairman

Dr. Geoffrey Ling
Independent Director

Dr. Phillip Alvelda
Chief Executive Officer

Zvi Huber
Chief Operating Officer

Shana McDevitt
Director, Clinical Genomics

Dr. Matthew Settles
Director of Bio-Informatics

Quynh-Anh Mai
Assc. Director of Operations
